Navigation Links
Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
Date:6/3/2008

Clinical Development. In addition, Judith A. Fox, Ph.D., has been promoted to Vice President, Product and Preclinical Development and Glenn C. Michelson, M.D., has been promoted to Vice President, Clinical Strategy.

To date, voreloxin has demonstrated objective responses in both solid and hematologic tumors and has been consistently well tolerated in multiple clinical trials. Sunesis is currently conducting Phase 2 clinical trials of voreloxin as a single agent for the treatment of platinum-resistant ovarian cancer and previously untreated acute myeloid leukemia (AML), as well as a Phase 1b clinical trial of voreloxin in combination with cytarabine in relapsed/refractory AML. Data recently reported at the 44th ASCO Annual Meeting in the Phase 2 ovarian cancer trial demonstrated that 48 percent of platinum-resistant ovarian cancer patients treated at a dose of 48 mg/m2 once every 21 days achieved disease control, defined as stable disease for 90 days or more or a complete or partial response. Preliminary median progression- free survival in this group of patients was 13 weeks at this dose; twenty- three patients at this dose remained on study as of May 12, 2008. Later this month, at the European Hematology Association Congress, Sunesis will report updated data on voreloxin's activity alone, and interim data on voreloxin's activity in combination with cytarabine for the treatment of AML.

Sunesis continues ongoing trials in its earlier-stage clinical programs, including the Phase 1 dose-escalation study of its cyclin-dependent kinase inhibitor, SNS-032, and its pan-Aurora kinase inhibitor, SNS-314, and expects to report data from these clinical trials this year. The company plans to seek a development partner to support advanced clinical trials of SNS-314. Future development of SNS-032 will depend on achieving positive results from the ongoing trial.

With the closing of its internal discovery research activities, Sunesis will also explore opportun
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
2. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
3. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
4. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
5. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
7. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
8. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
9. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
10. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014   Cypher Genomics, Inc., ... of J. Patrick Ravenel as chief technology ... software and systems experience and a proven track record ... "Patrick has been recognized as a ... systems and is known industry-wide for delivering innovative products ...
(Date:10/1/2014)... Mass. , Oct. 1, 2014   ... AEX: PHIA) today announced its eCareCoordinator and eCareCompanion ... U.S. Food and Drug Administration (FDA). A part ... telehealth programs , eCareCoordinator and eCareCompanion are focused ... the first clinical applications to be available through ...
(Date:10/1/2014)... R.I. , Oct. 1, 2014  CVS Health ... Month for their role in changing the way health ... improve quality in the Company,s retail pharmacies, mail service ... month, we changed our company name to CVS Health ... expertise in driving the innovations needed to shape the ...
Breaking Medicine Technology:Cypher Genomics Appoints J. Patrick Ravenel Chief Technology Officer 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3
... Further data shows PegIFN-λ,s ... New data presented at the International ... revolution in HCV treatment. The much anticipated data from ... combinations of antivirals offer the hope of shorter, more ...
... On Thursday, April 19, 2012, at 8:30 a.m. Eastern/2:30 ... Inc.,s (CTI) (NASDAQ and MTA: CTIC) management team will ... Numbers Thursday, April 19 8:30 a.m. ... (US Participants) 1-480-629-9692 (International) Call-back numbers for ...
Cached Medicine Technology:New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 2New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 3New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 4New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 5New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 6New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients 7
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
(Date:10/1/2014)... at the occasion of the Leishmaniasis East Africa ... and international leishmaniasis experts, results of a pharmacovigilance ... plan, carried out by MSF, DNDi, and ... were presented to key decision makers in order ... with the combination of Sodium Stibogluconate and Paromomycin ...
(Date:10/1/2014)... 2014 October is national Breast Cancer ... detection plans while raising money for breast cancer research. ... Awareness Month in the effort to find a ... the importance of having access to clean, healthy water. ... linked to certain forms of cancer. , The ...
(Date:10/1/2014)... HILLS, CA (PRWEB) October 01, 2014 ... cosmetic dentists and prosthodontists, is traveling to Chennai, ... Oral Implantologists on Oct. 2 and 3. , Dr. ... in Woodland Hills and Oxnard, Calif., and one of ... in teeth restoration and replacement. He is speaking to ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Two bicyclists ... take them across the country in an effort to ... military families. The cyclists, a father-daughter team, plan ... beginning in Blaine, Washington and finishing in Key West ... Hope For The Warriors®, a national nonprofit organization that ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2
... medical researchers in the United States has discovered what may ... cancer.// ,The scientists from the University of ... halting the activity of a single enzyme called aldose reductase. ... of biochemical signals that promotes inflammation and colon cancer cell ...
... of interest for post menopausal women with breast cancer ... Herceptin (trastuzumab) from Roche// and Arimidex (anastrozole) from AstraZeneca ... time by 4.8 months. ,A Phase III clinical ... the progression by just 2.4 months after which the ...
... people affected by chikungunya, a viral fever caused by mosquitoes//, ... the state government on the nature of the disease. ... not chikungunya. The government is doing its best to contain ... have asked people from other systems of medicines like Ayurveda ...
... an undiagnosed disorder and fighting to stay in Canada, has ... state after three years.// ,"I just hugged them... and ... parents landed at Vancouver airport last week. ,Dhaval ... Gujarat advised him to move after looking at his condition ...
... It was just weeks following the 9/11 attacks in ... offices of the news media and two US senators//. The ... five people and infected 17 others. , ,In a ... University of Georgia, teaming up with scientists at the federal ...
... and at times even forbid birthday cupcakes due to ... bring carrots," said Laura Ott, assistant to the superintendent.,A ... a sticker and a pencil instead of sweets from ... Unified School District, in Orange County, Calif., has restricted ...
Cached Medicine News:Health News:Indian with Rare Disorder Reunited with Family 2Health News:Cell-Wall Carbohydrate in Anthrax Bacterium Holds Promise for New Vaccines 2
Occluder and Maddox Rod...
Graham Field 10' Reversed Snellen Eye Chart....
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
... on Optics can be useful in the ... help while normalizing blood sugar. Post cataract ... -provide magnification. Accommodative esotropia - address residual ... placement. Sunglasses - add bifocals. Specialty - ...
Medicine Products: